Image

Interest of Parametric Positron Emission Imaging in the Diagnosis of Infections on Cardiac Valve Prosthesis

Interest of Parametric Positron Emission Imaging in the Diagnosis of Infections on Cardiac Valve Prosthesis

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The objective of this study is to determine if early parametric positron emission computed tomography is useful to diagnose cardiac prosthetic valve infections.

Description

In addition to routine examinations (biological and microbiological tests, transesophageal or transthoracic ultrasound, transesophageal or transthoracic ultrasound, and leukocyte scintigraphy) of a parametric acquisition during the positron emission computed tomography parametric acquisition during positron emission computed tomography , this examination being itself planned in a standard way.

The definitive diagnosis according to the Duke-Li criteria will be established three months later in a multidisciplinary consultation meeting.

The final diagnosis according to the Duke-Li criteria will be made three months later in a multidisciplinary consultation meeting, blinded to the results of the parametric positron emission computed tomography, and with knowledge of the results of the standard positron emission computed tomography and the entire work-up.

Results and all the complementary work-up.

Eligibility

Inclusion Criteria:

  • Age superior to18 years,
  • Effective contraception for women of childbearing age or negative pregnancy test on the day of the exam
  • Good general condition. WHO ≤ 1
  • Suspicion of endocarditis on a prosthetic heart valve implanted more than 3 months ago
  • Labeled polynuclear scintigraphy performed within a maximum of 15 days before positron emission computed tomography
  • Standard positron emission computed tomography planned as part of the extension assessment
  • Informed and signed consent before any specific study procedure.
  • Patient affiliated to the social security system

Exclusion Criteria:

  • Presence of an active cancer in the previous three years
  • Pregnancy or breastfeeding
  • Poorly controlled diabetic patients
  • Protected adults (under guardians or curators)
  • Impossible decubitus (orthopnea, ...),
  • Hypersensitivity to FDG or to one of the excipients of the radiopharmaceutical.

Study details
    Endocarditis

NCT05146180

Centre Henri Becquerel

30 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.